A clinical study has shown successful results in the reduction of endometriosis pain from a natural formulation of trace-metals.
The clinical trial explored the efficacy of an innovative formulation of trace-metals called Nutri Endo, developed by Laboratoires Pronutri, showing that it reduces pain by 66.1% in women suffering from endometriosis – an increasing pathology which is accompanied by intense chronic pain caused by the abnormal presence of endometrial cells outside the uterine cavity.
According to the Ministry of Solidarity and Health, France, endometriosis affects approximately 10% of women worldwide.
A natural pain solution
The formulation is a specific complex of trace-metals assembled in sequences, which is natural and free of undesirable side effects and is recommended for use for two months for early stages (I and II) or for prevention, and four months or more for stages III and IV and long-established endometriosis.
It has been submitted to a clinical study approved by regulatory authorities and ethics committees, and the study was conducted in several international centres on a randomised, double- blind, placebo-controlled basis in premenopausal women with a diagnosis of ASFr stages II, III and IV endometriosis. The results demonstrated that 91.3% of women regained quality of life following the study.
The innovation is aimed at women with various endometriotic profiles, from the preventive stage for the youngest (first menstruation) to the oldest, as well as women with a desire to procreate.
Pain is the main disabling symptom of the condition – with chronic pain preventing woman from leading a normal, professional, social, and intimate life, and can even lead to sterility. In case of surgery, the average post-operative recurrence rate is about 20% within five years. Cases of endometriosis are constantly on the rise, with a broadening of age groups developing the condition, and many young girls affected from the time of their first menstrual period.
